increased solubility = different PK profile? [Dissolution / BCS / IVIVC]

posted by nobody – 2017-06-08 19:43 (2844 d 00:41 ago) – Posting: # 17467
Views: 14,970

❝ O.k., I see I need to add some more information. The idea behind this question is to develop an oral formulation with a less drug load than the reference product but with the same bioavailability in order to decrease non-systemic adverse events.


If you claim less AEs, you will have to proof it. In my opinion. So: Clinical trials ahead, I guess.

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
22 visitors (0 registered, 22 guests [including 6 identified bots]).
Forum time: 19:25 CET (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5